3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Squamous Cell Carcinoma of Head and Neck
12
Oropharyngeal Neoplasms
12
Lung Neoplasms
9
Carcinoma
8
Mouth Neoplasms
7
Laryngeal Neoplasms
7
Mesothelioma, Malignant
6
Hypopharyngeal Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Uterine Cervical Neoplasms
5
Nasopharyngeal Carcinoma
5
Urinary Bladder Neoplasms
4
Pancreatic Neoplasms
4
Triple Negative Breast Neoplasms
3
Salivary Gland Neoplasms
3
Lymphoid Interstitial Pneumonia
3
Gallbladder Neoplasms
3
Testicular Neoplasms
2
Seminoma
2
Medulloblastoma
2
Ganglioneuroblastoma
2
Cholangiocarcinoma
2
Carcinoma, Transitional Cell
2
Breast Neoplasms
2
Adenocarcinoma of Lung
2
Wilms Tumor
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Tongue Neoplasms
1
Teratoma
1
Interventions
tusamitamab ravtansine
1
Platinum
1
Docetaxel
1
Bevacizumab
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Non-small Cell Lung Cancer Metastatic
×
Platinum
×
90 days
×
Clear all
NCT05407155
2026-04-23
BETTER
Fudan University
Phase NA
Active not recruiting
56 enrolled